Dr. Jain on the Use of Diagnostic Tracers in Prostate Cancer

Video

In Partnership With:

Manoj K. Jain, MD, discusses diagnostic tracers in prostate cancer.

Manoj K. Jain, MD, nuclear medicine specialist, radiologist, Mayo Clinic, discusses diagnostic tracers in prostate cancer.

F-18 fluciclovine (Axium) is commonly used at academic institutions because C-11 choline has a short half-life and requires an onsite cyclotron for the production of the tracer and for use, says Jain. However, one of the drawbacks of F-18 fluciclovine is that the supply from the vendor is only accessible on limited days.

However, Mayo Clinic is in the process of getting a cyclotron approval. After that, Mayo Clinic will be using C-11 choline, because it will be more readily available and will allow for easier scheduling, says Jain.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,